Pegalin ER 330 mg (Tablet (Extended Release))
Unit Price: ৳ 45.00 (1 x 10: ৳ 450.00)
Strip Price: ৳ 450.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Popular pharmaceuticals ltd |
| Also available as |
Title
- Pegalin ER 330 mg Tablet
Categories
- Neuropathic Pain Relief
- Anti-Epileptic Medication
- Fibromyalgia Management
- Seizure Control
Description
- Indicated for neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Dimensions
- Tablet size: 330 mg
Color Options
- NA
Functions
- Relieves neuropathic pain
- Controls seizures
- Manages fibromyalgia symptoms
Materials
- Active Ingredient: Pregabalin
Technical Specifications
- Maximum recommended dose: 100 mg three times a day for DPN; 75 to 150 mg two times a day for PHN; 300 to 450 mg/day for fibromyalgia; 150 to 600 mg/day for spinal cord injury
- Route of administration: Oral
- Dosage adjustment based on individual patient response and tolerability
- Recommended dose conversion from Pregabalin capsules to Pregabalin CR capsule tablet
Design Elements
- Extended-release formulation (ER)
Usability Features
- Can be taken with or without food
- Pregabalin CR tablet should be swallowed whole and not split, crushed or chewed
- Specific instructions for missed doses and discontinuation
Pharmacology
- Structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Binds with high affinity to the alpha2-delta site in central nervous system tissues
Interaction
- Unlikely to be involved in significant pharmacokinetic drug interactions
Contraindications
- Patients with known hypersensitivity to Pregabalin or any of its components
Side Effects
- Dizziness
- Somnolence
- Dry mouth
- Edema
- Blurred vision
- Weight gain
- Thinking abnormal
- Increased weight and appetite in pediatric patients
Pregnancy & Lactation
- Potential risk to fetus
- Not recommended during breastfeeding
Precautions & Warnings
- Angioedema
- Hypersensitivity reactions
- Increased risk of suicidal thoughts or behavior
- Respiratory depression
- May cause dizziness, somnolence, impaired ability to drive or operate machinery
- Increased seizure frequency if rapidly discontinued
- May cause peripheral edema
- Caution with coadministration of thiazolidinedione antidiabetic agents
Use in Special Populations
- Not established for pediatric patients with certain conditions
- Safety and effectiveness not established for pediatric patients below the age of 1 month
Overdose Effects
- Signs and symptoms include reduced consciousness, depression/anxiety, seizures, and heart block
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Keep below 30°C, protected from light and moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula : C8H17NO2
Common Questions
- What is Pegalin ER 330 mg XR Tablet?
- How long do I need to use Pegalin ER 330 mg XR Tablet before I see improvement in my condition?
- At what frequency do I need to use Pegalin ER 330 mg XR Tablet?
- Should I use Pegalin ER 330 mg XR Tablet empty stomach, before food or after food?
- Instructions for storage and disposal of Pegalin ER 330 mg XR Tablet
- Does Pegalin ER 330 mg XR Tablet work in the same way for each disease?
- How long do I need to take Pegalin ER 330 mg XR Tablet?
- Is it necessary to continue taking Pegalin ER 330 mg XR Tablet even if I feel fine?
- Can I take Diazepam and Pegalin ER 330 mg XR Tablet together?
- Can the use of Pegalin ER 330 mg XR Tablet cause weight gain?
- Quick Tips
Drug Classes
- Anticonvulsant